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BSTETRICS
odulation of vaginal immune response among pregnant
omen with bacterial vaginosis by Trichomonas vaginalis,
hlamydia trachomatis, Neisseria gonorrhoeae, and yeast
abina Cauci, PhD; Jennifer Flatow Culhane, PhDBJECTIVE: This study was undertaken to examine the influence of
oinfections on vaginal innate and adaptive immunity, and microbial
nzyme activities of pregnant women with bacterial vaginosis (BV).
TUDY DESIGN: The population consisted of 265 singleton pregnant
omen in early gestation (20 weeks) with BV (Nugent 7-10) who had
aginal fluid collected for measurement of interleukin-1 (IL-1) and
L-8 concentrations, number of neutrophils, immunoglobulin A against
ardnerella vaginalis (anti-Gvh IgA), and activities of microbial siali-
ase and prolidase.
ESULTS: Among women with BV, median levels of vaginal IL-1 (4-
old, P .005), IL-8 (4-fold, P .001), and neutrophils (6-fold, Pof preterm birth or th
oi: 10.1016/j.ajog.2006.08.033omen without any coinfection. Yeast increased the level of IL-8 (5-
old, P .001), but not IL-1 (P .239) and neutrophils (P .060).
hlamydia trachomatis and Neisseria gonorrhoeae had no effect on
aginal cytokines. None of the coinfections influenced vaginal anti-Gvh
gA, sialidase and prolidase activities.
ONCLUSION: The strong proinflammatory cytokine induction by T
aginalis may contribute to the observed increase in preterm birth
mong BV positive women coinfected with T vaginalis treated with
etronidazole.
ey words: adverse pregnancy outcome, bacterial vaginosis,
nterleukin-1, interleukin-8, prolidase, sialidase, Trichomonas013) were greatly increased in women with T vaginalis with respect to vaginalis, vaginal neutrophils
ite this article as: Cauci S, Flatow Culhane J. Modulation of vaginal immune response among pregnant women with bacterial vaginosis by Trichomonas
aginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and yeast. Am J Obstet Gynecol 2007;196;133.e1-133.e7.
vidence suggests that the profile of
vaginal immune and microbial bi-
markers has an impact on adverse preg-
ancy outcomes related to infection.1– 4
nnate immunity is considered the first
line of mucosal defense against mi-
crobes, in part via the induction of an
array of proinflammatory cytokines and
antimicrobial factors, and in part by
stimulation of the adaptive immuno-
logic response. However, many features
of the innate vaginal response to mi-
crobes are not yet understood.1,4 Im-
proved understanding of the regulation
of local immunity could provide insight
into the nature of the relationship be-
tween vaginal infections and adverse
birth outcomes,1 and/or human immu-
nodeficiency virus (HIV) acquisition
and transmission.5,6
Vaginal infections such as bacterial
vaginosis (BV) and Trichomonas vagina-
lis in pregnant women have been associ-
ated with preterm birth.7–12 However,
the pathophysiology underpinning these
relationships is not known. Recent stud-
ies have demonstrated that treatment of
BV in pregnancy with antibiotics clears
the infection but does not reduce the risk
sociated adverse outcomes.13–15 In a
study with alarming results, metronida-
zole treatment in women with T vagina-
lis reduced the infection rate but in-
creased the incidence of preterm birth.16
Understanding the alterations in vaginal
mucosal immune profiles associated
with BV and T vaginalis coinfection may
help to elucidate the confusing results of
antibiotic treatment.12
BV is a complex polymicrobial disor-
der characterized by depletion of lacto-
bacilli and overgrowth of a mixed vari-
able anaerobic and facultative flora,
including Gardnerella vaginalis, Pre-
votella spp, Bacteroides spp, Mobiluncus
spp, gram-positive cocci, and genital
mycoplasma. Sialidases and prolidases
are enzymes produced by anaerobic bac-
teria likely involved in the pathogenesis
of BV.17,18 The action of these hydrolytic
enzymes can potentially alter the im-
mune signals and promote the degrada-
tion of host factors.17–19 A recent study
onDanish pregnant women showed that
high sialidase and/or prolidase activity
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1reater, are strong risk factors for early
reterm birth (32 weeks of gestation),
ow birthweight (LBW), and very LBW
1500 g at birth).20 In the same popu-
ation, high levels of specific immuno-
lobulin A (IgA) against the toxin pro-
uced by G vaginalis (anti-Gvh IgA)
ere protective for adverse pregnancy
utcomes.21
BV is not characterized by an increase
f vaginal polymorphonuclear neutro-
hils (PMN), unlike trichomoniasis,
hich usually provokes a large increase
f PMN.11 However, BV and trichomo-
iasis are both characterized by an ele-
ated vaginal pH (4.5), and malodor-
us discharge. Frequently, women with
V also have other vaginal infections, es-
eciallyT vaginalis, C trachomatis, andN
onorrhoeae.12,22,23 A recent study
howed that BVwas positively associated
ith trichomoniasis with odds ratio
OR) 5.93 (95%CI 1.34-26.24), and
hlamydia and/or gonorrheawithOR
.87 (95% CI  1.21-65.09).23
Increasing evidence points to interleu-
in (IL)-1 as a crucial cytokine, which
ay mediate reproductive tract infec-
ion-related adverse outcomes.1,2,24,25
enc et al25 proposed an exaggerated
aginal IL-1 response, possibly linked
o genetic polymorphisms, as a risk fac-
or for adverse pregnancy outcome.
L-1 is a master proinflammatory cyto-
ine responsible for a cascade of innate
nd adaptive responses.26 IL-1 rises in
esponse to several stimuli, including a
ast array of pathogens. Increased vagi-
al concentrations of IL-1 have been
onsistently found in women with BV,
nd HIV.27–30 In vaginal fluid, IL-1 was
ositively associated with IL-8 (CXCL8)
 potent chemokine.29 Both of these
roinflammatory cytokines were consis-
ently correlatedwith the number of vag-
nal neutrophils, in healthy and BV-pos-
tive women.4,27,29 Though a number of
tudies have examined vaginal immunity
n BV positive women, few investiga-
ions have examined the modulation of
aginal immunity by T vaginalis in BV-
ositive women. A study showed that
aginal discharges of symptomatic
richomoniasis patients had large
mounts of IL-8.31 However, to our
nowledge, there are no data on the ef- m
33.e2 American Journal of Obstetrics & Gynecolects of T vaginalis on vaginal levels of
L-1 in pregnant women with BV.
In this investigation, we explored the
ole of concurrent vaginal infections,
uch asT vaginalis, C trachomatis, N gon-
rrhoeae, and yeast on vaginal concen-
rations of IL-1 and IL-8, number of
eutrophils, anti-Gvh IgA, and sialidase
nd prolidase activities in pregnant
omen with BV.
ATERIALS AND METHODS
ll women enrolling for prenatal care at
hree hospital-based clinics and 1 com-
unity-based clinic between Jan. 1,
002, and Sept. 7, 2004, were screened
or eligibility into the study. Women
ere considered eligible for participa-
ion if they: (1) were less than 20 weeks
regnant at the time of enrollment, (2)
poke either English or Spanish, (3) had
singleton intrauterine pregnancy, (4)
ere not HIV positive, (5) did not seek a
herapeutic abortion, (6) were 18 years
f age or older, (7) underwent a routine
elvic examination at the enrollment
isit, and (8) had no vaginal bleedings at
he time of recruitment.
At the time of enrollment, participants
ere interviewed by trained female in-
erviewers to ascertain awide array of de-
ographic, behavioral, psychosocial,
nd medical history data. In addition to
his self-reported information, vaginal
ecretions were obtained from the poste-
ior wall of the vaginal fornix at the time
f routine speculumexamination.Of the
swabs collected, 5 were inoculated into
terile saline solution and immediately
nap frozen in liquid nitrogen. Two
wabs were used to create air-dried vag-
nal smears. Air-dried vaginal smears
ere stained and assessed for BV accord-
ng to Nugent criteria.32 A score of 0-3
as considered normal, a score of 4-6
orresponded to intermediate BV status,
nd a score of 7-10 was defined as posi-
ive for BV. Neutrophils and clue cells
ere determined on the Gram-stained
mear at 1000magnification in 5 non-
djacent fields. For statistical calcula-
ions, number of neutrophils was set
qual to 40 whenmore than 30, and per-
ent of clue cells was set equal to 30when
ore than 20%.28,29 Neutrophil counts s
ogy FEBRUARY 2007ere not available for 2 women in this
tudy. After assessing the BV status of
articipants, a random sample of 265
V-positive women was chosen. For
hese women, we retrieved and analyzed
aginal fluid from 5 thawed swabs. Sam-
les were centrifuged at 700g for 3 min-
tes at 4°C and the supernatant was ali-
uoted and immediately frozen and
tored at80°C.
BV-positive women were further di-
ided into mutually exclusive groups ac-
ording to the presence of concurrent
aginal infections. T vaginaliswas evalu-
ted byXenostrip examination (MPBio-
edicals LLC, BurlingameCA).Diagno-
is of N gonorrhoeae, and C trachomatis
as based on urine nucleic acid amplifi-
ation by the APTIMA Combo 2 Assay
Gen-Probe, Inc, San Diego, CA), which
s a nucleic acid probe using target cap-
ure for ribosomal RNA. Yeast vaginal
olonization was determined by pres-
nce of hyphae and/or yeast spores in the
ram-stained smear.
IL-1 (Sanquin, Amsterdam, The
etherlands) and IL-8 (BenderMed Sys-
ems, San Bruno, CA) were quantified in
he vaginal fluid by commercial enzyme-
inked immunosorbent assay (ELISA)
its and measurements were performed
ccording to themanufacturer’s instruc-
ions.29 The intra- and interassay coeffi-
ient variations for both assays were less
han 10%. The lower detection limit was
pg/mL for human IL-1, and 8 pg/mL
or IL-8. Fifteen women had undetect-
ble IL-1, and 2 women had undetect-
ble IL-8 levels. Values greater than the
5thpercentilewere consideredhigh lev-
ls of ILs, those below the 25th percentile
ere considered low levels, and values
etween the 25th and the 75th percentile
ere considered medium levels.
Sialidase activity was determined by
ncubation of 50 L of the vaginal sam-
le with the specific substrate at pH 5.0,
s described previously.21 Sialidase activ-
ty was expressed as nanomoles of con-
erted substrate (methoxyphenol) pro-
uced by comparison with a standard
urve of pure methoxyphenol. Prolidase
ctivitywas determined as previously de-
cribed by use of a chromogenic sub-
trate.21 Absorbance in milliopitcal den-
ity units (mOD) was read at 405 nm.
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www.AJOG.org Obstetrics ResearchValues of anti-Gvh IgAwere evaluated
y ELISA in mOD units read at 405 nm
s described.21
All measurements were performed in
uplicate.
tatistical analysis
ytokine concentrations were not nor-
ally distributed, thus the Mann-Whit-
ey U test was used to compare vaginal
actor levels between BV subgroups. Dif-
erence of proportions was assessed by a
-tailed Fisher’s 2 exact test. The
ruskal-Wallis test was used to compare
or more groups. Any P value less than
05 was considered statistically signifi-
ant. The software package SPSS (Statis-
ical Package for Social Sciences, Chi-
ago, IL) was used for data analyses.
ESULTS
emographic characteristics, number
percent) or mean  SD values, of the
ntire cohort of 265 pregnant women
ith BV are shown in Table 1. The ma-
ority of participants were black, single,
onsidered low income, and at enroll-
ent, were in early gestation (mean 11.7
3.59 weeks of gestation).
Two hundred (200/265  75.5%)
omen had BV without any coinfection
BV controls). Only 1 woman had syph-
lis and was excluded from further anal-
ses, leaving a total cohort of 264 BV-
ositive women. Of the remaining 64
V-positive women, 26 were coinfected
ith yeast, 12 were coinfected with T
aginalis, 9 with C trachomatis, and 1
ith N gonorrhoeae. In addition, 6 BV-
ositive women were coinfected with
oth T vaginalis and C trachomatis, 5
ith C trachomatis andN gonorrhoeae, 2
ith yeast and T vaginalis, 1 with T vagi-
alis andN gonorrhoeae, 1 withN gonor-
hoeae and yeast, and 1 withC trachoma-
is and yeast. Thus, a total of 21 women
ad vaginalis (21/264  8.0%), 21
omen had C trachomatis (21/264 
.0%), 8 women had N gonorrhoeae (8/
64  3.0%) and, 30 women had yeast
30/26411.4%).
Table 2 shows levels of vaginal bi-
markers (median and interquartile val-
es) for the entire cohort. Wide ranges
or vaginal biomarkers were observed. In bddition, Table 2 compares vaginal bi-
marker values betweenBV controls and
omen with only 1 coinfection, with the
xception of the 1 woman coinfected
ith N gonorrhoeae. Of note, women
ithBVandTvaginalishadmuchhigher
oncentrations of IL-1 (4.2-fold, P 
005), IL-8 (4.1-fold, P .001), and neu-
rophils (6-fold, P  .013) compared
ith those with BV alone. However, T
aginalis had no influence on sialidase
nd prolidase activities or anti-Gvh IgA
evels. On the contrary, the percent of
lue cells was lower in the BV-positive T
aginalis group when compared with the
V-positive control group. The BV-pos-
tive C trachomatis group was not differ-
nt from controls for any vaginal
TABLE 1
Demographic characteristics of th
enrolled
Characteristic
Black (non-Hispanic)
...................................................................................................................
Hispanic
...................................................................................................................
White (non-Hispanic)
...................................................................................................................
Others
...................................................................................................................
Nulliparity
...................................................................................................................
Posthigh school education
...................................................................................................................
High school completed
...................................................................................................................
High school not completed
...................................................................................................................
Single
...................................................................................................................
Maternal age (y)
...................................................................................................................
Gestation (wk)
...................................................................................................................
Yearly income (US $)
...................................................................................................................
Smoking
...................................................................................................................
Ever smoked 20 or more cigarette per week
...................................................................................................................
Number of cigarettes per week before pregn
...................................................................................................................
Douching in the year before pregnancy
...................................................................................................................
Frequency of douching per week
...................................................................................................................
Lifetime sexual partners
...................................................................................................................
7 or more sexual partners lifetime
...................................................................................................................
T vaginalis
...................................................................................................................
C trachomatis
...................................................................................................................
N gonorrhoeae
...................................................................................................................
Yeast
...................................................................................................................
Syphilisiomarker. Interestingly, additional col- I
FEBRUARY 2007 Americanization with yeast had no influence on
L-1 levels in BV-positive women.
owever, yeast induced a large increase
f the chemokine IL-8 (5.3-fold, P 
001), and tended to increase neutrophils
2.2-fold, P  .060) with respect to BV
ontrols. Yeast coinfection had no effect
n sialidase, prolidase, or anti-Gvh IgA
evels. The BV-positive yeast positive
roup had a slightly lower number of
lue cells compared with BV controls.
By using the IL-1 values obtained
rom the entire study sample (n 264),
e constructed cut points for 3 catego-
ies; low ( 25th percentile,  36 pg/
L), medium (from the 25th to the 75th
ercentile, 36-399 pg/mL), and high (
5th percentile,  399 pg/mL) levels of
65 BV-positive pregnant women
Frequency or
mean  SD or %
73.2%
..................................................................................................................
21.4%
..................................................................................................................
4.3%
..................................................................................................................
1.2%
..................................................................................................................
40.5%
..................................................................................................................
22.0%
..................................................................................................................
44.8%
..................................................................................................................
33.2%
..................................................................................................................
75.7%
..................................................................................................................
24.2 5.18
..................................................................................................................
11.7 3.59
..................................................................................................................
11822 11305
..................................................................................................................
32.4%
..................................................................................................................
ong smokers 35.1%
..................................................................................................................
y among smokers 23.5 48.59
..................................................................................................................
51.5%
..................................................................................................................
0.20 0.44
..................................................................................................................
6.3 8.37
..................................................................................................................
25.1%
..................................................................................................................
8.3%
..................................................................................................................
7.9%
..................................................................................................................
3.0%
..................................................................................................................
11.3%
..................................................................................................................
0.38%e 2
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
am
.........
anc
.........
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.........
.........
.........
.........L-1 (Table 3). T vaginalis was more
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133.e4 Amerrequently found in thehigh IL-1 group
14/65 21.5%) than in themedium (6/
35  4.4%) and low IL-1 (1/64 
.6%) groups, P .001. Eight C tracho-
atis-positive women had high IL-1
evels (8/65  12.3%), but 5 of them
ere also T vaginalis positive. The fre-
uency of N gonorrhoeae and yeast was
ot different in the IL-1 subgroups.
We further examined the frequency of
oinfections according to progressive
evels of vaginal IL-8 in the 264 pregnant
omenwith BV by using a similarmeth-
dology. Table 4 compares women with
ow ( 25th percentile,  680 pg/mL),
edium (from the 25th to the 75th per-
entile, 680-6994 pg/mL), and high (
5th percentile, 6994 pg/mL) levels of
L-8. Approximately 20% of women
ith high levels of IL-8 were T vaginalis
ositive vs 0% of women in the lower
L-8 group (P .001). In addition, 24%
f women with high levels of IL-8 were
east positive vs 6.1% in the medium
L-8 group (P  .001), and 9.1% in the
ower IL-8 group (P .034).
Finally, Table 5 shows the frequency of
oinfections in subgroups of women
ith increasing levels of vaginal neutro-
hils. The only coinfection significantly
ore frequent in the high neutrophil
roup was T vaginalis.
OMMENT
ntil recently, most studies describing
he association between BV and adverse
utcomes have not explored the host/
icrobial interactions at the level of the
aginal mucosa.1,2,4 To our knowledge,
his study is the largest investigation of
odulation of vaginal immunity in
regnantwomenwithBVwith andwith-
ut concurrent infections. In addition to
omen exclusively infected with BV, we
ocused on those coinfected with T vagi-
alis, C trachomatis, N gonorrhoeae, and
east.
This study focused on vaginal IL-1
evels as this cytokine is one of the main
roinflammatory factors able to activate
nnate and adaptive immunity against
icrobes. The “downstream” effects of
n IL-1 induced cascade include activa-
ion of white cells to kill microorganisms
and should therefore be beneficial to the
T C c V I I . N . S . P . % . A . M T * †
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www.AJOG.org Obstetrics Researchost.26 However, if the immune re-
ponse is exaggerated, elevated levels of
L-1 could be harmful to the host
hrough induction of an excessive in-
ammatory reaction.1,2,25 Thus, the
argin between beneficial and adverse
ffects of IL-1 may be fairly narrow.
ifferent signals by many different
athogens can trigger a rise of this pleio-
ropic cytokine. In our study we found a
ide range of IL-1 concentrations (0-
125 pg/mL) in vaginal fluid of 264 preg-
ant women with BV with and without
oinfections. Concurrent infection with
vaginalis was able to modulate IL-1
evels in BV-positive women. T vaginalis
as a powerful inducer of IL-1, increas-
ng median levels 4-fold with respect to
V-positive women without any con-
urrent infection. This is not surprising,
iven that T vaginalis is a protozoa
nown to induce a strong inflammatory
esponse in vaginal mucosa.4,11,31 How-
ver, the actual levels of vaginal proin-
TABLE 3
Frequency of coinfections in 264 w
Coinfection
Low IL-1
(n  64) P
T vaginalis 1 (1.6%)
...................................................................................................................
C trachomatis 1 (1.6%)
...................................................................................................................
N gonorrhoeae 1 (1.6%)
...................................................................................................................
Yeast 6 (9.4%) 
...................................................................................................................
Low (25th percentile, 36 pg/mL), medium (25th-75th pe
* 2-sided Fisher’s exact test comparing low vs medium IL-1
† 2-sided Fisher’s exact test comparing medium vs high IL-1
‡ 2-sided Fisher’s exact test comparing low vs high IL-1 
§ Kruskal-Wallis test applied to the 3 groups.
TABLE 4
Frequency of coinfections in 264 w
Coinfection
Low IL-8
(n  66) P
T vaginalis 0 (0%) .
...................................................................................................................
C trachomatis 5 (7.6%) .
...................................................................................................................
N gonorrhoeae 3 (4.6%) .
...................................................................................................................
Yeast 6 (9.1%) .
...................................................................................................................
Low (25th percentile,  680 pg/mL), medium (25th-75th p
* 2-sided Fisher’s exact test comparing low vs medium IL-8
† 2-sided Fisher’s exact test comparing medium vs high IL-8
‡ 2-sided Fisher’s exact test comparing low vs high IL-8 gro
§ Kruskal-Wallis test applied to the 3 groups.ammatory cytokines in pregnant
omen with BV and T vaginalis have
ever been reported before.
It is worth mentioning that around
0% of BV-positive women with high
evels of IL-1 in our sample were also
nfected with T vaginalis. This suggests
hat the proportion of women with BV
nd high IL-1 levels may vary accord-
ng to the prevalence of concurrent in-
ection withT vaginalis in the study pop-
lation; a finding that has serious
mplications for studies comparing US
regnantwomen andwomen fromother
ocations with lower rates of trichomo-
iasis, for example Western European
amples.12 The difference in coinfection
ateswithT vaginalis amongBV-positive
omenmay account for the lack of asso-
iation between BV and adverse preg-
ancy outcomes in studies conducted on
uropean population.21 In addition, the
uccess of antibiotic treatment in BV-
ositive women found in some Euro-
en with BV according to IL-1 lev
Medium IL-1
(n  135)
High IL-1
(n  65)
33 6 (4.4%) 14 (21.5%)
.........................................................................................................................
65 12 (8.9%) 8 (12.3%)
.........................................................................................................................
33 6 (4.4%) 1 (1.5%)
.........................................................................................................................
9 13 (9.6%) 11 (16.9%)
.........................................................................................................................
ile, 36-399 pg/mL), and high (75th percentile,  399 pg/mL
ups.
roups.
s.
en with BV according to IL-8 level
Medium IL-8
(n  132)
High IL-8
(n  66)
8 (6.1%) 13 (19.7%)
.........................................................................................................................
8 (6.1%) 8 (12.1%)
.........................................................................................................................
3 (2.3%) 2 (3.0%)
.........................................................................................................................
8 (6.1%) 16 (24.2%)
.........................................................................................................................
ntile, 680-6994 pg/mL), and high (75th percentile,  6994 pg
ps.
ups.FEBRUARY 2007 Americaean studies14,15 may be attributable to a
ower rate of coinfection with other sex-
ally transmitted infections (STIs). Even
ithin geographically similar popula-
ions, demographic characteristics like
ace may impact the link between BV
nd reproductive outcomes through dif-
erential rates of coinfection with STIs
eading to alterations in vaginal im-
unity.1,4,33 For example, a large study
f midgestation pregnant American
omen showed race-specific prevalence
ate of trichomoniasis: 22.8% for black;
.6% for Hispanic and 6.1% for white
omen.33 A weakness of our study to as-
ess T vaginalis prevalence was the use of
he XenoStrip rapid test that has a sensi-
ivity of 77-90% and a specificity of 93-
9% when compared with culture.34
In our study, C trachomatis had no ef-
ect on vaginal proinflammatory cyto-
ines andneutrophils. These findings are
n line with a recent study performed in
onpregnant women demonstrating
in vaginal fluid
P† P‡ P§
 .001  .001  .001
..................................................................................................................
.459 .033 .067
..................................................................................................................
.431  .99 .392
..................................................................................................................
.164 .298 .267
..................................................................................................................
ues of vaginal IL-1 concentrations were compared.
n vaginal fluid
P† P‡ P§
.003 .001 .001
..................................................................................................................
.169 .561 .330
..................................................................................................................
.99 .99 .680
..................................................................................................................
.001 .034 .001
..................................................................................................................
) values of vaginal IL-1 concentrations were compared.om els
*
.4
......... .........
.0
......... .........
.4
......... .........
.9
......... .........
rcent ) val
 gro
 g
groupom s i
*
054
......... .........
763
......... .........
402
......... .........
557
......... .........
erce /mL
grou
gro
ups.n Journal of Obstetrics & Gynecology 133.e5
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1hat IL-1 and IL-8 levels were not differ-
nt in cervical secretions ofC trachomatis
ositive compared with uninfected con-
rol women.35 We did not observe an in-
reased proinflammatory response in
aginal fluid associated with BV and N
onorrhoeae infection. Our results con-
ur with observations of other authors
boutN gonorrhoeae infection at vaginal
evel.4,36 Interestingly, we found that
aginal yeast colonization did not influ-
nce IL-1, significantly increased IL-8
oncentrations, and only marginally in-
reased neutrophils. Possibly, augmen-
ation of vaginal cytokines in response to
east infection involves a pattern of host
hite cells different from that involved
n nonfungal infections, ie, including
ainly mast cells, which when stimu-
ated produce large amounts of
L-8.4,11,37,38 Because yeast colonization
s not generally considered a risk factor
or adverse pregnancy outcomes, it is
empting to speculate that an increase in
aginal IL-1, more than an increase in
L-8 per se, confers risk in pregnant
omen. A limitation of our study con-
isted in evaluation of yeast colonization
y Gram stain, which has a reduced sen-
itivity compared with yeast culture
ethods.11
None of the concurrent infections
tudied modulated the levels of sialidase
nd prolidase activities in women with
V. This observation is consistent with
he fact thatT vaginalis, C trachomatis, N
onorrhoeae and yeast are not known to
roduce these specific enzymes, which
TABLE 5
Frequency of coinfections in 264 w
on the Gram-stained vaginal smea
Coinfection
Low neutrophils
(n  68)
T vaginalis 2 (2.9%)
...................................................................................................................
C trachomatis 3 (4.4%)
...................................................................................................................
N gonorrhoeae 2 (2.9%)
...................................................................................................................
Yeast 5 (7.4%)
...................................................................................................................
Low (25th percentile, 0 number), medium (25th-75th perc
* 2-sided Fisher’s exact test comparing low vs medium neut
† 2-sided Fisher’s exact test comparing medium vs high neu
‡ 2-sided Fisher’s exact test comparing low vs high neutroph
§ Kruskal-Wallis test applied to the 3 groups.re peculiar to anaerobic bacteria H
33.e6 American Journal of Obstetrics & Gynecolresent in theBVmilieu. In addition, it is
f note that the vaginal-specific IgA re-
ponse (anti-Gvh IgA) in BV-positive
omen was not modulated by any coin-
ection. Anti-Gvh IgA response is con-
idered protective against adverse preg-
ancy outcomes,21 thus it appears that
oinfections are not involved in damp-
ning this adaptive response in BV-pos-
tive pregnant women, this observation
ould be important in future immune
odulation strategies aimed to increase
ost defenses.
An excessive or unbalanced release of
roinflammatory factors may alter the
ucosal balance between tissue destruc-
ion and repair and be linked to en-
anced penetration and replication of
acterial/viral pathogens. High levels of
L-1have been suggested as a risk factor
or preterm birth.25 Our current results
how that induction of high levels of vag-
nal IL-1 can derive from different mi-
robial signals. In our population of
ainly black women at 12 weeks of ges-
ation with BV, 21.5% of high IL-1 re-
ponders were also T vaginalis positive.
urther studies should assess if women
ith elevated vaginal IL-1with orwith-
ut T vaginalis infection are at increased
isk of preterm birth.
BV in pregnancy has been consistently
ssociated with several adverse out-
omes, including spontaneous preterm
elivery, and LBW.7–9 In addition, BV
as been associated with upper genital
ract infections, urinary infections, and
ncreased risk of sexual acquisition of
en with BV according to neutrophi
Medium neutrophils
(n  126)
High neu
(n  68)
498 7 (5.6%) 12 (17.6%
.........................................................................................................................
266 12 (9.5%) 6 (8.8%
.........................................................................................................................
99 4 (3.2%) 2 (2.9%
.........................................................................................................................
459 15 (11.9%) 10 (14.7%
.........................................................................................................................
, 0-10 number), and high (75th percentile,  10 number) va
ls groups.
ils groups.
roups.IV and herpes simplex virus type 2 w
ogy FEBRUARY 2007HSV-2) infection.4,23 The association of
richomoniasis with the above men-
ioned adverse outcomes is much more
ontroversial.12 Even weaker are associ-
tions of C trachomatis39 and yeast infec-
ions with adverse pregnancy outcomes.4
his suggests that a large induction of
aginal IL-1 and/or IL-8 may not nec-
ssarily be a risk factor for adverse out-
ome unless such increase is accompa-
ied by other (largely uncharacterized)
egative events induced by microorgan-
sms and/or determined by the host
ackground.
In summary, the overall scenario in
V is multifaced. Our results indicate
hat the presence of concurrent infec-
ions may produce different immune
rofiles in BV-positive women. It was
reviously known that BV induces high
evels of vaginal IL-1 in comparison to
ealthy women,2 but it was not esti-
ated to what extent concurrent infec-
ionsmodulate levels of IL-1 in BVpos-
tive women. We first determined that
mong the infections commonly found
n parallel with BV, only T vaginalis af-
ected IL-1. On the other hand, vaginal
evels of IL-8 were positively modulated
y both T vaginalis and yeast, 2 vaginal
yndromes known to cause clinically ev-
dent vaginal inflammatory signs and
ymptoms with leukocyte accumulation
n vaginal secretions.
Our hypothesis is that the combina-
ion of specific immune/enzyme/micro-
ial factors can determine the final risk
or adverse outcome among BV-positive
levels in vaginal fluid determined
phils
P† P‡ P§
.010 .009 .003
..................................................................................................................
 .99 .493 .440
..................................................................................................................
 .99  .99 .994
..................................................................................................................
.655 .273 .395
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www.AJOG.org Obstetrics Researchherapeutic interventions could be asso-
iatedwith themicrobial/immunity pro-
le of a given BV-positive pregnant
oman. We cannot assess this issue on
he population presently examined as
his study was not designed to assess
reatment of BV. If our hypothesis is sup-
orted by further evidence, the immune/
nzyme/microbial profile should be
aken into account when developing in-
ervention trials. Finally, it seems advis-
ble that future therapeutic treatments
im tomodulate local immunity in addi-
ion to eradicating microorganisms.40 f
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